Diversis Capital

Diversis Capital is a Los Angeles-based private equity firm that partners with technology companies to accelerate growth and create market leaders. Founded in 2013, the firm focuses on investing in software and technology-enabled services organizations, primarily targeting lower middle-market companies in North America, Western Europe, and Australasia. Diversis Capital manages over $3 billion in assets and has raised over $1 billion in institutional capital across its fund vehicles.

The firm's investment strategy emphasizes operationally focused control private equity investments, aiming to add unique value by providing both growth capital and operational guidance. Diversis Capital seeks companies with proven, recurring revenue business models and the potential to be market leaders. The firm looks for opportunities to accelerate top-line growth both organically, through best practices, and inorganically, through accretive mergers and acquisitions.

Diversis Capital maintains a collaborative approach to investing, with its Operating Partners and Strategic Advisors working alongside management teams to build successful organizations positioned for long-term growth. The firm has a track record of successful investments, including the acquisition and transformation of BLUE Software in 2014, which was sold in 2018. In 2025, Diversis Capital closed its third fund, Diversis Capital Partners III, L.P., at $1.2 billion, surpassing its $850 million target and bringing the firm's total assets under management to over $3 billion.

Diversis Capital's portfolio includes companies such as Genesis Automation Healthcare, Kermit, and Meperia, which were combined in 2025 to create the first end-to-end healthcare supply chain and inventory management platform. The firm continues to focus on investments across North America and Europe, leveraging its deep bench of operating partners and domain experts to drive innovation and growth in its portfolio companies.